Depression and the older medical patient - When and how to intervene

Maturitas

Volumn 79, Issue 2, 2014, Pages 153-159

  Mitchell, Philip B ^a,b   Harvey, Samuel B ^a,b,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b BLACK DOG INSTITUTE   (Australia)

^c ST GEORGE HOSPITAL   (Australia)

Author keywords

Depression; Depressive; Elderly; Medical; Old age; Physical

Indexed keywords

ANTIDEPRESSANT AGENT; CYTOCHROME P450; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEPRESSION; FUNCTIONAL DISEASE; GERIATRIC DISORDER; HEALTH; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART RATE VARIABILITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; MORBIDITY; MORTALITY; NEOPLASM; NURSING HOME PATIENT; OSTEOPOROSIS; PARKINSON DISEASE; PHYSICAL DISEASE; REVIEW; SYMPTOMATOLOGY; THROMBOCYTE ACTIVATION; TREATMENT OUTCOME; AGED; CARDIOVASCULAR DISEASES; COMORBIDITY; COOPERATION; DEPRESSIVE DISORDER; DISEASE MANAGEMENT; NEOPLASMS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RENAL INSUFFICIENCY, CHRONIC;

AGED; CARDIOVASCULAR DISEASES; COMORBIDITY; COOPERATIVE BEHAVIOR; DEPRESSION; DEPRESSIVE DISORDER; DISEASE MANAGEMENT; HUMANS; NEOPLASMS; PARKINSON DISEASE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RENAL INSUFFICIENCY, CHRONIC;

EID: 84916888315     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2014.05.010     Document Type: Review

References (71)

1. Byers AL, Yaffe K, Covinsky KE, Friedman MB, Bruce ML. High occurrence of mood and anxiety disorders among older adults: The National Comorbidity Survey Replication. Arch Gen Psychiatry 2010;67:489-96.
2. Mojtabai R. Diagnosing depression in older adults in primary care. N Engl J Med 2014;370:1180-2.
3. Almeida OP, Alfonso H, Hankey GJ, Flicker L. Depression, antidepressant use and mortality in later life: the health in men study. PLoS ONE 2010;5:e11266.
4. Mitchell AJ, Subramaniam H. Prognosis of depression in old age compared to middle age: a systematic review of comparative studies. Am J Psychiatry 2005;162:1588-601.
5. Kok RM, Nolen WA, Heeren TJ. Efficacy of treatment in older depressed patients: a systematic review and meta-analysis of double-blind randomized controlled trials with antidepressants. J Affect Disord 2012;141:103-15.
6. Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ 2011;343:d4551.
7. van der Weele GM, de Waal MW, van den Hout WB, et al. Effects of a stepped-care intervention programme among older subjects who screened positive for depressive symptoms in general practice: the PROMODE randomised controlled trial. Age Ageing 2012;41:482-8.
8. Clarke DM. Growing old and getting sick: maintaining a positive spirit at the end of life. Aust J Rural Health 2007;15:148-54.
9. Harvey SB, Ismail K. Psychiatric aspects of chronic physical disease. Medicine 2008;36:471-4.
10. Pfaff JJ, Draper BM, Pirkis JE, et al. Medical morbidity and severity of depression in a large primary care sample of older Australians: the DEPS-GP project. Med J Aust 2009;190:S75-80.
11. Taylor D, Meader N, Bird V, et al. Pharmacological interventions for people with depression and chronic physical health problems: systematic review and meta-analyses of safety and efficacy. Br J Psychiatry 2011;198:179-88.
12. Caughey GE, Roughead EE, Shakib S, McDermott RA, Vitry AI, Gilbert AL. Comorbidity of chronic disease and potential treatment conflicts in older people dispensed antidepressants. Age Ageing 2010;39:488-94.
13. Llewellyn-Jones RH, Snowdon J. Depression in nursing homes: ensuring adequate treatment. CNS Drugs 2007;21:627-40.
14. Boyce RD, Hanlon JT, Karp JF, Kloke J, Saleh A, Handler SM. A review of the effectiveness of antidepressant medications for depressed nursing home residents. J Am Med Dir Assoc 2012;13:326-31.
15. Katon WJ, Lin EH, Von Korff M, et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med 2010;363:2611-20.
16. Leontjevas R, Gerritsen DL, Smalbrugge M, Teerenstra S, Vernooij-Dassen MJ, Koopmans RT. A structural multidisciplinary approach to depression management in nursing-home residents: a multicentre, stepped-wedge cluster-randomised trial. Lancet 2013;381:2255-64.
17. Whang W, Kubzansky LD, Kawachi I, et al. Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study. J Am Coll Cardiol 2009;53:950-8.
18. Kimmel SE, Schelleman H, Berlin JA, et al. The effect of selective serotonin reuptake inhibitors on the risk of myocardial infarction in a cohort of patients with depression. Br J Clin Pharmacol 2011;72:514-7.
19. Huang CJ, Hsieh MH, Hou WH, Liu JC, Jeng C, Tsai PS. Depression, antidepressants, and the risk of coronary heart disease: a population-based cohort study. Int J Cardiol 2013;168:4711-6.
20. Mavrides N, Nemeroff C. Treatment of depression in cardiovascular disease. Depress Anxiety 2013;30:328-41.
21. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA 1993;270:1819-25.
22. Colquhoun DM, Bunker SJ, Clarke DM, et al. Screening, referral and treatment for depression in patients with coronary heart disease. Med J Aust 2013;198:483-4.
23. Thombs BD, Roseman M, Coyne JC, et al. Does evidence support the American Heart Association's recommendation to screen patients for depression in cardiovascular care? An updated systematic review. PLoS ONE 2013;8:e52654.
24. Whooley MA, de Jonge P, Vittinghoff E, et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 2008;300:2379-88.
25. Morel-Kopp MC, McLean L, Chen Q, et al. The association of depression with platelet activation: evidence for a treatment effect. J Thromb Haemost 2009;7:573-81.
26. Glassman AH, O'Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002;288:701-9.
27. Thombs BD, de Jonge P, Coyne JC, et al. Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA 2008;300:2161-71.
28. de Jonge P, Honig A, van Melle JP, et al. Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events. Am J Psychiatry 2007;164:1371-8.
29. Scherrer JF, Chrusciel T, Garfield LD, et al. Treatment-resistant and insufficiently treated depression and all-cause mortality following myocardial infarction. Br J Psychiatry 2012;200:137-42.
30. Labos C, Dasgupta K, Nedjar H, Turecki G, Rahme E. Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction. CMAJ 2011;183:1835-43.
31. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003;289:3106-16.
32. Morgan MAJ, Coates MJ, Dunbar JA, Reddy P, Schlicht K, Fuller J. The True-Blue model of collaborative care using practice nurses as a case managers for depression alongside diabetes or heart disease: a randomised trial. BMJ Open 2013:3.
33. Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 2006;48:1527-37.
34. Diez-Quevedo C, Lupon J, Gonzalez B, et al. Depression, antidepressants, and long-term mortality in heart failure. Int J Cardiol 2013;167:1217-25.
35. Jiang W, O'Connor C, Silva SG, et al. Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): a randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure. Am Heart J 2008;156:437-44.
36. O'Connor CM, Jiang W, Kuchibhatla M, et al. Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol 2010;56:692-9.
37. Fraguas R, da Silva Telles RM, Alves TC, et al. A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms. Contemp Clin Trials 2009;30:205-11.
38. Veien KT, Videbaek L, Schou M, et al. High mortality among heart failure patients treated with antidepressants. Int J Cardiol 2011;146:64-7.
39. Robinson RG. Poststroke depression: prevalence, diagnosis, treatment, and disease progression. Biol Psychiatry 2003;54:376-87.
40. Hornsten C, Lovheim H, Gustafson Y. The association between stroke, depression, and 5-year mortality among very old people. Stroke 2013;44:2587-9.
41. Carson AJ, MacHale S, Allen K, et al. Depression after stroke and lesion location: a systematic review. Lancet 2000;356:122-6.
42. Hackett ML, Anderson CS. Predictors of depression after stroke: a systematic review of observational studies. Stroke 2005;36:2296-301.
43. Rampello L, Battaglia G, Raffaele R, Vecchio I, Alvano A. Is it safe to use antidepressants after a stroke? Expert Opin Drug Saf 2005;4:885-97.
44. Ramasubbu R, Taylor VH, Samaan Z, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and select comorbid medical conditions. Ann Clin Psychiatry 2012;24:91-109.
45. Hackett ML, Anderson CS, House A, Xia J. Interventions for treating depression after stroke. Cochrane Database Syst Rev 2008:CD003437.
46. Currier MB, Nemeroff CB. Depression as a risk factor for cancer: from pathophysiological advances to treatment implications. Annu Rev Med 2014;65:203-21.
47. Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliativecare settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 2011;12:160-74.
48. Mystakidou K, Parpa E, Tsilika E, et al. Geriatric depression in advanced cancer patients: the effect of cognitive and physical functioning. Geriatr Gerontol Int 2013;13:281-8.
49. Laoutidis ZG, Mathiak K. Antidepressants in the treatment of depression/depressive symptoms in cancer patients: a systematic review and meta-analysis. BMC Psychiatry 2013;13:140.
50. Jacobsen PB, Jim HS. Psychosocial interventions for anxiety and depression in adult cancer patients: achievements and challenges. CA Cancer J Clin 2008;58:214-30.
51. Sheard T, Maguire P. The effect of psychological interventions on anxiety and depression in cancer patients: results of two meta-analyses. Br J Cancer 1999;80:1770-80.
52. Torta RG, Ieraci V. Pharmacological management of depression in patients with cancer: practical considerations. Drugs 2013;73:1131-45.
53. Palmer S, Vecchio M, Craig JC, et al. Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int 2013;84:179-91.
54. Bautovich A, Katz I, Smith M, Loo CK, Harvey SB. Depression and chronic kidney disease: a review for clinicians. Aust N Z J Psychiatry 2014 [e-published March 21].
55. Hedayati SS, Minhajuddin AT, Afshar M, Toto RD, Trivedi MH, Rush AJ. Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or death. JAMA 2010;303: 1946-53.
56. Chilcot J, Davenport A, Wellsted D, Firth J, Farrington K. An association between depressive symptoms and survival in incident dialysis patients. Nephrol Dial Transplant 2011;26:1628-34.
57. Kimmel PL, Peterson RA, Weihs KL, et al. Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients. Kidney Int 2000;57:2093-8.
58. Koo JR, Yoon JY, Joo MH, et al. Treatment of depression and effect of antidepression treatment on nutritional status in chronic hemodialysis patients. Am J Med Sci 2005;329:1-5.
59. Palmer SC, Vecchio M, Craig JC, et al. Association between depression and death in people with CKD: a meta-analysis of cohort studies. Am J Kidney Dis 2013;62:493-505.
60. Hedayati SS, Finkelstein FO. Epidemiology, diagnosis, and management of depression in patients with CKD. Am J Kidney Dis 2009;54:741-52.
61. Cohen LM, Tessier EG, Germain MJ, Levy NB. Update on psychotropic medication use in renal disease. Psychosomatics 2004;45:34-48.
62. Yuan Y, Tsoi K, Hunt RH. Selective serotonin reuptake inhibitors and risk of upper GI bleeding: confusion or confounding? Am J Med 2006;119: 719-27.
63. Fan VS, Ramsey SD, Giardino ND, et al. Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med 2007;167:2345-53.
64. Janssen DJ, Spruit MA, Leue C, et al. Symptoms of anxiety and depression in COPD patients entering pulmonary rehabilitation. Chron Respir Dis 2010;7:147-57.
65. Norwood R, Balkissoon R. Current perspectives on management of co-morbid depression in COPD. COPD 2005;2:185-93.
66. Fritzsche A, Clamor A, von Leupoldt A. Effects of medical and psychological treatment of depression in patients with COPD - a review. Respir Med 2011;105:1422-33.
67. Pirraglia PA, Charbonneau A, Kader B, Berlowitz DR. Adequate initial antidepressant treatment among patients with chronic obstructive pulmonary disease in a cohort of depressed veterans. Prim Care Companion J Clin Psychiatry 2006;8:71-6.
68. Coventry PA, Bower P, Keyworth C, et al. The effect of complex interventions on depression and anxiety in chronic obstructive pulmonary disease: systematic review and meta-analysis. PLoS ONE 2013;8:e60532.
69. Aarsland D, Pahlhagen S, Ballard CG, Ehrt U, Svenningsson P. Depression in Parkinson disease - epidemiology, mechanisms and management. Nat Rev Neurol 2012;8:35-47.
70. Rocha FL, Murad MG, Stumpf BP, Hara C, Fuzikawa C. Antidepressants for depression in Parkinson's disease: systematic review and meta-analysis. J Psychopharmacol 2013;27:417-23.
71. Barone P, Poewe W, Albrecht S, et al. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2010;9:573-80.